CHU de SAINT-ETIENNE
Saint-Etienne, 42000, France
NCT Number: NCT02913651
Autonomic nervous system dysfunction has been described in narcolepsy with cataplexy affecting the sympathetic function. In this study the investigators analyzed whether altered diurnal and nocturnal cardiovascular control is present in idiopathic hypersomnia. Drug-free patients diagnosed with idiopathic hypersomnia and age-matched controls were included. Clinical data, 24-h polysomnography, heart rate variability and the heart rate response to spontaneous arousal are analyzed.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Saint-Etienne, 42000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Idiopathic hypersomnia patients
Inclusion criteria
no idiopathic hypersomnia patients
Exclusion criteria
(both):
The polysomnography, for both groups, was performed accordance with standard practice
Time frame: During the polysomnography (one night)
Nocturnal parasympathetic activity (HF parameter of heart rate variability analysis)
Time frame: During the polysomnography (one night)
HRV is measured by the polysomnography. It is a composite outcome : Standard Deviation of NN intervals (SDNN), the proportion of NN30 (and 50) divided by total number of NNs (pNN30, pNN50), Root Mean Square of Successive Differences (RMSSD), Standard Deviation type 1 and 2 (SD1, SD2), Low Frequencies (LF), Very Low Frequencies (VLF), LF/HF ratio and Ptot indexes
Time frame: During the polysomnography (one night)
Time frame: Before the polysomnography (one night)
It examines eight different situations using a 4-grade scale ranging from 0 (no chances of napping) to 3 (high chances of napping). Subjects were defined as sleepy if they had an ESS>10
Centre Hospitalier Universitaire de Saint Etienne
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05615584
Cataplexy, Disorders of Excessive Somnolence
Montpellier, France
View Trial DetailsNCT05059223
Cataplexy, Disorders of Excessive Somnolence
Alabaster, Alabama, United States
View Trial DetailsNCT05113745
Cataplexy, Disorders of Excessive Somnolence
Phoenix, Arizona, United States
View Trial DetailsNCT04451668
Cataplexy, Disorders of Excessive Somnolence
Birmingham, Alabama, United States
View Trial Details